Literature DB >> 4316981

Azathioprine in pemphigus vulgaris.

J L Burton, M W Greaves, J Marks, R P Dawber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4316981      PMCID： PMC1701060          DOI： 10.1136/bmj.3.5714.84

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  10 in total

1.  METHOTREXATE-INDUCED HEPATIC INJURY IN AN ADULT. A CASE REPORT.

Authors:  R A O'ROURKE; G E ECKERT
Journal:  Arch Intern Med       Date:  1964-02

2.  DEMONSTRATION OF SKIN ANTIBODIES IN SERA OF PEMPHIGUS VULGARIS PATIENTS BY INDIRECT IMMUNOFLUORESCENT STAINING.

Authors:  E H BEUTNER; R E JORDON
Journal:  Proc Soc Exp Biol Med       Date:  1964-11

3.  Treatment of pemphigus with corticosteroids. Results obtained in 46 patients over a period of 11 years.

Authors:  W F LEVER; H WHITE
Journal:  Arch Dermatol       Date:  1963-01

4.  Cirrhosis caused by methotrexate in the treatment of psoriasis.

Authors:  S A Muller; G M Farrow; D L Martalock
Journal:  Arch Dermatol       Date:  1969-11

5.  Cirrhosis associated with methotrexate treatment of psoriasis.

Authors:  R O Coe; F E Bull
Journal:  JAMA       Date:  1968-11-11       Impact factor: 56.272

Review 6.  Azathioprine therapy of "autoimmune" diseases.

Authors:  C C Corley; H E Lessner; W E Larsen
Journal:  Am J Med       Date:  1966-09       Impact factor: 4.965

7.  In vitro evaluation of immunosuppressive drugs.

Authors:  J F Bach; M Dardenne; C Fournier
Journal:  Nature       Date:  1969-06-07       Impact factor: 49.962

8.  Pemphigus vulgaris successfully treated with cyclophosphamide.

Authors:  A Ebringer; I R Mackay
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

9.  Pemphigus vulgaris.

Authors:  A Krakowski; J Covo; Z Rozanski
Journal:  Arch Dermatol       Date:  1969-07

10.  Treatment of pemphigus vulgaris with methotrexate.

Authors:  W F Lever; H S Goldberg
Journal:  Arch Dermatol       Date:  1969-07
  10 in total
  4 in total

Review 1.  Recent advances in the diagnosis and treatment of pemphigus.

Authors:  V D Newcomer; J W Landau
Journal:  Calif Med       Date:  1971-02

Review 2.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

3.  Intermittent cyclophosphamide in pemphigus vulgaris and bullous pemphigoid.

Authors:  A Medved; I Maxwell
Journal:  Can Med Assoc J       Date:  1974-08-03       Impact factor: 8.262

4.  Effect of NUDT15 polymorphisms on early hematological safety of low-dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study.

Authors:  Xingli Zhou; Liangliang Cheng; Yiyi Wang; Hui Gou; Ke Ju; TianJiao Lan; Tongying Zhan; GaoJie Li; Yuanxia Gu; Yeting Sun; Yan Xu; Yukun Sun; Yanhong Zhou; Wei Li
Journal:  J Dermatol       Date:  2021-12-05       Impact factor: 3.468
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.